| pubmed-article:11953016 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11953016 | lifeskim:mentions | umls-concept:C0026473 | lld:lifeskim |
| pubmed-article:11953016 | lifeskim:mentions | umls-concept:C1510802 | lld:lifeskim |
| pubmed-article:11953016 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:11953016 | lifeskim:mentions | umls-concept:C0079411 | lld:lifeskim |
| pubmed-article:11953016 | lifeskim:mentions | umls-concept:C0333668 | lld:lifeskim |
| pubmed-article:11953016 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:11953016 | pubmed:dateCreated | 2002-4-15 | lld:pubmed |
| pubmed-article:11953016 | pubmed:abstractText | DC generated from monocytes have been used for vaccines. We have developed a monocyte enrichment procedure by depleting T and B cells with anti-CD2 and anti-CD19 Abs using the automated Isolex 300i magnetic cell selector for clinical-scale DC generation in gas permeable SteriCell culture bags. We have also compared DC function, yield and purity of DC generated from adherent monocytes using culture bags in a closed system, with DC generated in conventional tissue culture flasks. | lld:pubmed |
| pubmed-article:11953016 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11953016 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11953016 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11953016 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11953016 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11953016 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11953016 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11953016 | pubmed:issn | 1465-3249 | lld:pubmed |
| pubmed-article:11953016 | pubmed:author | pubmed-author:LeeS MSM | lld:pubmed |
| pubmed-article:11953016 | pubmed:author | pubmed-author:SuetCC | lld:pubmed |
| pubmed-article:11953016 | pubmed:author | pubmed-author:HouSS | lld:pubmed |
| pubmed-article:11953016 | pubmed:author | pubmed-author:BenderJ GJG | lld:pubmed |
| pubmed-article:11953016 | pubmed:author | pubmed-author:BunnC WCW | lld:pubmed |
| pubmed-article:11953016 | pubmed:author | pubmed-author:LoudovarisMM | lld:pubmed |
| pubmed-article:11953016 | pubmed:author | pubmed-author:OfsteinGG | lld:pubmed |
| pubmed-article:11953016 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11953016 | pubmed:volume | 3 | lld:pubmed |
| pubmed-article:11953016 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11953016 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11953016 | pubmed:pagination | 365-75 | lld:pubmed |
| pubmed-article:11953016 | pubmed:dateRevised | 2008-4-24 | lld:pubmed |
| pubmed-article:11953016 | pubmed:meshHeading | pubmed-meshheading:11953016... | lld:pubmed |
| pubmed-article:11953016 | pubmed:meshHeading | pubmed-meshheading:11953016... | lld:pubmed |
| pubmed-article:11953016 | pubmed:meshHeading | pubmed-meshheading:11953016... | lld:pubmed |
| pubmed-article:11953016 | pubmed:meshHeading | pubmed-meshheading:11953016... | lld:pubmed |
| pubmed-article:11953016 | pubmed:meshHeading | pubmed-meshheading:11953016... | lld:pubmed |
| pubmed-article:11953016 | pubmed:meshHeading | pubmed-meshheading:11953016... | lld:pubmed |
| pubmed-article:11953016 | pubmed:meshHeading | pubmed-meshheading:11953016... | lld:pubmed |
| pubmed-article:11953016 | pubmed:meshHeading | pubmed-meshheading:11953016... | lld:pubmed |
| pubmed-article:11953016 | pubmed:meshHeading | pubmed-meshheading:11953016... | lld:pubmed |
| pubmed-article:11953016 | pubmed:meshHeading | pubmed-meshheading:11953016... | lld:pubmed |
| pubmed-article:11953016 | pubmed:meshHeading | pubmed-meshheading:11953016... | lld:pubmed |
| pubmed-article:11953016 | pubmed:meshHeading | pubmed-meshheading:11953016... | lld:pubmed |
| pubmed-article:11953016 | pubmed:meshHeading | pubmed-meshheading:11953016... | lld:pubmed |
| pubmed-article:11953016 | pubmed:meshHeading | pubmed-meshheading:11953016... | lld:pubmed |
| pubmed-article:11953016 | pubmed:meshHeading | pubmed-meshheading:11953016... | lld:pubmed |
| pubmed-article:11953016 | pubmed:meshHeading | pubmed-meshheading:11953016... | lld:pubmed |
| pubmed-article:11953016 | pubmed:meshHeading | pubmed-meshheading:11953016... | lld:pubmed |
| pubmed-article:11953016 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11953016 | pubmed:articleTitle | Comparison of monocyte enrichment by immuno-magnetic depletion or adherence for the clinical-scale generation of DC. | lld:pubmed |
| pubmed-article:11953016 | pubmed:affiliation | Nexell Therapeutics, Inc., Cellular Biology, 9 Parker, Irvine, CA 92618, USA. | lld:pubmed |
| pubmed-article:11953016 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11953016 | pubmed:publicationType | Comparative Study | lld:pubmed |
